43 related articles for article (PubMed ID: 12845661)
1. Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.
Schröder CP; Ruiters MHJ; de Jong S; Tiebosch ATMG; Wesseling J; Veenstra R; de Vries J; Hoekstra HJ; de Leij LFMH; de Vries EGE
Int J Cancer; 2003 Sep; 106(4):611-618. PubMed ID: 12845661
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes.
Abdul-Rasool S; Kidson SH; Panieri E; Dent D; Pillay K; Hanekom GS
J Clin Pathol; 2006 Mar; 59(3):289-97. PubMed ID: 16505281
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies.
Weissenstein U; Schumann A; Reif M; Link S; Toffol-Schmidt UD; Heusser P
BMC Cancer; 2012 May; 12():206. PubMed ID: 22646670
[TBL] [Abstract][Full Text] [Related]
4. Non-radioactive hybridization in microwells using enzyme linked immune sorbent assay for detection of RT-PCR-amplified CK19- and CEA-mRNA.
Zhong X; Kaul S; Eichler A; Bastert G
J Tongji Med Univ; 1999; 19(3):181-4, 189. PubMed ID: 12840889
[TBL] [Abstract][Full Text] [Related]
5. Technical limits of comparison of step-sectioning,immunohistochemistry and RT-PCR on breast cancer sentinel nodes: a study on methacarn-fixed tissue.
Daniele L; Annaratone L; Allia E; Mariani S; Armando E; Bosco M; Macrì L; Cassoni P; D'Armento G; Bussolati G; Cserni G; Sapino A
J Cell Mol Med; 2009 Sep; 13(9B):4042-50. PubMed ID: 18671755
[TBL] [Abstract][Full Text] [Related]
6. An EGP-2/Ep-CAM-expressing transgenic rat model to evaluate antibody-mediated immunotherapy.
McLaughlin PM; Kroesen BJ; Dokter WH; van der Molen H; de Groot M; Brinker MG; Kok K; Ruiters MH; Buys CH; de Leij LF
Cancer Immunol Immunother; 1999 Sep; 48(6):303-11. PubMed ID: 10473805
[TBL] [Abstract][Full Text] [Related]
7. Advancing canine mammary tumor diagnostics: Unraveling the diagnostic potential of Cytokeratin 19 through droplet digital PCR analysis.
Tanvetthayanont P; Yata T; Boonnil J; Temisak S; Ponglowhapan S
Theriogenology; 2024 Mar; 217():127-135. PubMed ID: 38271766
[TBL] [Abstract][Full Text] [Related]
8. The detection of circulating breast cancer cells in blood.
Gilbey AM; Burnett D; Coleman RE; Holen I
J Clin Pathol; 2004 Sep; 57(9):903-11. PubMed ID: 15333648
[TBL] [Abstract][Full Text] [Related]
9. Potential of fluorescent metalloproteinase substrates for cancer detection.
Roy R; Zurakowski D; Pories S; Moss ML; Moses MA
Clin Biochem; 2011 Dec; 44(17-18):1434-9. PubMed ID: 22001071
[TBL] [Abstract][Full Text] [Related]
10. TUMOR MARKERS EXPRESSION LEVELS IN GASTRIC CANCER PATIENT'S PERIPHERAL BLOOD BY RT-PCR ASSESSMENT.
Kawakami GDS; Pereira MA; Kubrusly MS; Carrasco AGM; Ramos MFKP; Ribeiro Júnior U
Arq Bras Cir Dig; 2024; 36():e1789. PubMed ID: 38324850
[TBL] [Abstract][Full Text] [Related]
11. Detection limits of several commercial reverse transcriptase enzymes: impact on the low- and high-abundance transcript levels assessed by quantitative RT-PCR.
Levesque-Sergerie JP; Duquette M; Thibault C; Delbecchi L; Bissonnette N
BMC Mol Biol; 2007 Oct; 8():93. PubMed ID: 17953766
[TBL] [Abstract][Full Text] [Related]
12. Validation of droplet digital PCR for cytokeratin 19 mRNA detection in canine peripheral blood and mammary gland.
Tanvetthayanont P; Yata T; Boonnil J; Temisak S; Ponglowhapan S
Sci Rep; 2022 Aug; 12(1):13623. PubMed ID: 35948591
[TBL] [Abstract][Full Text] [Related]
13. Circulating nucleic acids as biomarkers in breast cancer.
Schwarzenbach H
Breast Cancer Res; 2013; 15(5):211. PubMed ID: 24090167
[TBL] [Abstract][Full Text] [Related]
14. High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood.
Martin KJ; Graner E; Li Y; Price LM; Kritzman BM; Fournier MV; Rhei E; Pardee AB
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2646-51. PubMed ID: 11226293
[TBL] [Abstract][Full Text] [Related]
15. Identifying biomarkers and surrogates of tumors (cancer biometrics): correlation with immunotherapies and immune cells.
Lotze MT; Rees RC
Cancer Immunol Immunother; 2004 Mar; 53(3):256-61. PubMed ID: 14735318
[TBL] [Abstract][Full Text] [Related]
16. A molecular computational model improves the preoperative diagnosis of thyroid nodules.
Tomei S; Marchetti I; Zavaglia K; Lessi F; Apollo A; Aretini P; Di Coscio G; Bevilacqua G; Mazzanti C
BMC Cancer; 2012 Sep; 12():396. PubMed ID: 22958914
[TBL] [Abstract][Full Text] [Related]
17. Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood.
Mikolajczyk SD; Millar LS; Tsinberg P; Coutts SM; Zomorrodi M; Pham T; Bischoff FZ; Pircher TJ
J Oncol; 2011; 2011():252361. PubMed ID: 21577258
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer.
Cheng M; Chen Y; Yu X; Tian Z; Wei H
BMC Cancer; 2008 May; 8():156. PubMed ID: 18513434
[TBL] [Abstract][Full Text] [Related]
19. A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients.
Xi L; Coello MC; Litle VR; Raja S; Gooding WE; Yousem SA; El-Hefnawy T; Landreneau RJ; Luketich JD; Godfrey TE
Clin Cancer Res; 2006 Apr; 12(8):2484-91. PubMed ID: 16638856
[TBL] [Abstract][Full Text] [Related]
20. Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: current and resolving controversies on the basis of the European Institute of Oncology experience.
Viale G; Mastropasqua MG; Maiorano E; Mazzarol G
Virchows Arch; 2006 Mar; 448(3):241-7. PubMed ID: 16362823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
